1. What were the top biotech IPOs in 2019? — Coronovirus could threaten US drug supplies — Novartis gets a boost in blockbuster MS race — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Spotlight on: Therapeutic Specialties boards

Discussion in 'CP Bulletin' started by cafead, Mar 12, 2019 at 4:51 PM.

Thread Status:
Not open for further replies.
  1. cafead

    cafead Administrator
    Staff Member

    Nov 21, 2001
    Likes Received:
    Today we’re starting a series that will spotlight various categories on the cafepharma message boards. The messageboards have quite a few categories, and users may often go straight to their favorite board or spot, without even being aware that some of the categories exist. We’re going to highlight some of the less frequented categories for you.

    This week we’ll look at the therapeutic specialties boards. Each board contains general discussion for reps and others working in a specific therapeutic area. The discussions range from general ones about working in the therapeutic space, to different companies that may not yet have a board on cafepharma.

    We currently have therapeutic specialty boards for the following. If you have a request for an additional board in this category, please contact us and let us know.

    Therapeutic Specialties boards
    • Anesthesia
    • Cardiology
    • Chronic Pain
    • Dermatology
    • Endocrinology
    • Gastroenterology
    • HIV Reps
    • Home Healthcare Reps
    • Hospital Reps
    • Nephrology/Dialysis Reps
    • Long Term Care Reps
    • Neurology
    • Oncology
    • Ophthalmology
    • Osteoporosis
    • Oxygen Reps
    • Pediatric Specialty
    • Plastic Surgery Reps
    • Podiatry
    • Psychiatry
    • Respiratory
    • Urology
    • Vaccines
    • Women’s Health
    • Wound Healing

Thread Status:
Not open for further replies.